Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maculopathy,Age-related”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)WithdrawnNCT04075136
What this trial is testing

Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy

Who this might be right for
Exudative Age Related Macular Degeneration
Wake Forest University Health Sciences
Large-scale testing (Phase 3)Study completedNCT04857177
What this trial is testing

Evaluate CKD-701 and Lucentis® in Patients With Neovascular(Wet) Age Related Macular Degeneration

Who this might be right for
Neovascular(Wet) Age Related Macular Degeneration
Chong Kun Dang Pharmaceutical 312
Not applicableStudy completedNCT00963339
What this trial is testing

Age-Related Macular Degeneration (AMD) - Usability Study

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 54
Not applicableStudy completedNCT01546181
What this trial is testing

Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases

Who this might be right for
Retinal DystrophiesAge-related Macular DegenerationArterial Hypertension+3 more
Institut National de la Santé Et de la Recherche Médicale, France 256
Not applicableActive Not RecruitingNCT06717139
What this trial is testing

Recurrence and Predictive OCT Biomarkers in Quiescent Neovascular AMD

Who this might be right for
Retinal DiseasesMacular DegenerationNeovascular (Wet) Age-Related Macular Degeneration
St. Erik Eye Hospital 220
Not applicableStudy completedNCT00329277
What this trial is testing

Detection of Topographic Residual Acuity in Patients With Age Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
University Health Network, Toronto 30
Large-scale testing (Phase 3)Looking for participantsNCT07064759
What this trial is testing

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
4D Molecular Therapeutics 480
Not applicableStudy completedNCT00563979
What this trial is testing

Enhancement of Macular Pigment Density by Oral Lutein Supplementation

Who this might be right for
Age-Related Maculopathies
Insel Gruppe AG, University Hospital Bern 80
Not applicableUnknownNCT06076720
What this trial is testing

Evaluation of New Head-mounted Visual Aids Among Patients With Low Vision

Who this might be right for
GlaucomaAge-related Macular DegenerationRetinitis Pigmentosa+1 more
Zhongshan Ophthalmic Center, Sun Yat-sen University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06990269
What this trial is testing

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
ADARx Pharmaceuticals, Inc. 240
Testing effectiveness (Phase 2)Study completedNCT03345082
What this trial is testing

A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Opthea Limited 366
Not applicableStudy completedNCT03630562
What this trial is testing

Assay of Pro-angiogenic Cytokines in Exudative Age-Related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
Centre Hospitalier Universitaire de Nice 100
Testing effectiveness (Phase 2)Study completedNCT00211458
What this trial is testing

Treatment of Age-Related Macular Degeneration With Anecortave Acetate

Who this might be right for
Macular Degeneration
Manhattan Eye, Ear & Throat Hospital
Not applicableLooking for participantsNCT07164378
What this trial is testing

International Study of the SING IMT™ Prosthesis in Pseudophakic patiEnts With Stable Moderate to Profound Bilateral Central vIsion Impairment Due to adVancEd AMD / PERSPECTIVE Study

Who this might be right for
Age - Related Macular Degeneration (AMD)
VisionCare, Inc. 44
Large-scale testing (Phase 3)Study completedNCT00593450
What this trial is testing

Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial

Who this might be right for
Age Related Macular Degeneration
University of Pennsylvania 1,208
Not applicableStudy completedNCT00603850
What this trial is testing

Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 25
Early research (Phase 1)Study completedNCT03144999
What this trial is testing

Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59

Who this might be right for
Dry Age-related Macular Degeneration
Janssen Research & Development, LLC 17
Not applicableStudy completedNCT01442064
What this trial is testing

An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Genentech, Inc. 608
Testing effectiveness (Phase 2)Study completedNCT00776763
What this trial is testing

Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab

Who this might be right for
Proliferative Diabetic RetinopathyAge Related Macular Degeneration
Ophthalmological Association Edelweiss 150
Large-scale testing (Phase 3)Study completedNCT00891735
What this trial is testing

Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR)

Who this might be right for
Age-related Macular Degeneration
Genentech, Inc. 1,097
Next Page